B-Cell Lymphoma Protected by SPAK Silencing A group led by Dr. Michael Teitell at UCLA has demonstrated that misregulation of the protein SPAK may contribute to B-cell lymphoma development. Their report can be found in the October 2009 issue of the American Journal of Pathology. B-cell lymphomas are the most frequent human immune system cancers.